Trademark Overview
On Monday, March 16, 2026, a trademark application was filed for R1TX with the United States Patent and Trademark Office. The USPTO has given the R1TX trademark a serial number of 99706076. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 16, 2026. This trademark is owned by R1 Therapeutics, Inc.. The R1TX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of neurological, immunological, nephrological, oncological, infectious, cardiovascular, vascular, central and peripheral nervous system, autoimmune, endocrinological, gastrointestinal, genetic, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, ocular, neuromuscular, and viral diseases, conditions and disorders